Literature DB >> 31521886

Injectable and degradable methacrylic acid hydrogel alters macrophage response in skeletal muscle.

Miranda M Carleton1, Michael V Sefton2.   

Abstract

After severe trauma, skeletal muscle cannot repair itself leading to scar tissue formation and functional impairment. A novel approach to overcome this issue is to alter the fibrotic response in muscle using regenerative biomaterials, such as those containing methacrylic acid (MAA). In the skin, MAA-based materials have been shown to promote wound healing and new vessel formation, through endogenous mechanisms, including macrophage polarization; however, MAA has yet to be studied outside the skin. To study the innate immune response to MAA in skeletal muscle, MAA-poly(ethylene glycol) (MAA-PEG) hydrogels were synthesized with degradation rates of either 2 (fast-degrading) or 7 days (slow-degrading). When injected into the tibialis anterior muscle of mice, both slow- and fast-degrading MAA hydrogels increased the expression of Il-10, Tnfα and M2 macrophage markers (Fizz1 and Arg for slow-and fast-degrading, respectively). Moreover, the slow degrading MAA hydrogel decreased the number of pro-inflammatory MHCII+ macrophages. An unbiased t-distributed stochastic neighbor embedding (tSNE) analysis suggested the involvement of other immune cells beyond just macrophages in the effect of MAA on skeletal muscle. Overall, this study shows that MAA hydrogels bias macrophages towards a pro-regenerative phenotype.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hydrogel; Macrophage polarization; Methacrylic acid; Skeletal muscle

Year:  2019        PMID: 31521886     DOI: 10.1016/j.biomaterials.2019.119477

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Engineering multifunctional bioactive citrate-based biomaterials for tissue engineering.

Authors:  Min Wang; Peng Xu; Bo Lei
Journal:  Bioact Mater       Date:  2022-05-07

2.  Chitosan@Puerarin hydrogel for accelerated wound healing in diabetic subjects by miR-29ab1 mediated inflammatory axis suppression.

Authors:  Xiaoling Zeng; Baohui Chen; Luping Wang; Yingxiao Sun; Zhao Jin; Xuanyong Liu; Liping Ouyang; Yun Liao
Journal:  Bioact Mater       Date:  2022-05-11

Review 3.  Biological approaches for hypertrophic scars.

Authors:  Zhong Lingzhi; Li Meirong; Fu Xiaobing
Journal:  Int Wound J       Date:  2019-12-20       Impact factor: 3.315

Review 4.  Mobilizing Endogenous Repair Through Understanding Immune Reaction With Biomaterials.

Authors:  Maria Karkanitsa; Parinaz Fathi; Tran Ngo; Kaitlyn Sadtler
Journal:  Front Bioeng Biotechnol       Date:  2021-11-30

5.  Cell-loaded injectable gelatin/alginate/LAPONITE® nanocomposite hydrogel promotes bone healing in a critical-size rat calvarial defect model.

Authors:  Bin Liu; Junqin Li; Xing Lei; Sheng Miao; Shuaishuai Zhang; Pengzhen Cheng; Yue Song; Hao Wu; Yi Gao; Long Bi; Guoxian Pei
Journal:  RSC Adv       Date:  2020-07-07       Impact factor: 4.036

6.  Amelogenin Downregulates Interferon Gamma-Induced Major Histocompatibility Complex Class II Expression Through Suppression of Euchromatin Formation in the Class II Transactivator Promoter IV Region in Macrophages.

Authors:  Karen Yotsumoto; Terukazu Sanui; Urara Tanaka; Hiroaki Yamato; Rehab Alshargabi; Takanori Shinjo; Yuki Nakao; Yukari Watanabe; Chikako Hayashi; Takaharu Taketomi; Takao Fukuda; Fusanori Nishimura
Journal:  Front Immunol       Date:  2020-04-21       Impact factor: 7.561

Review 7.  Next Stage Approach to Tissue Engineering Skeletal Muscle.

Authors:  Gregory Reid; Fabio Magarotto; Anna Marsano; Michela Pozzobon
Journal:  Bioengineering (Basel)       Date:  2020-09-30

Review 8.  Local Immunomodulatory Strategies to Prevent Allo-Rejection in Transplantation of Insulin-Producing Cells.

Authors:  Xi Wang; Natalie K Brown; Bo Wang; Kaavian Shariati; Kai Wang; Stephanie Fuchs; Juan M Melero-Martin; Minglin Ma
Journal:  Adv Sci (Weinh)       Date:  2021-07-14       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.